Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of clinical trials
-
By
-
Artem Oganesyan
-
Andrew Gregory
-
Mark Gregory
-
Deivid Badalian
-
Asatur Chakmanyan
-
Lusine Harutyunyan
-
Vahe Khachatryan
-
Abhay Aradhya
-
Aheed Javaid
-
Yervand Hakobyan
-
Christian J Fidler
-
Pierluigi Porcu
-
June 26, 2026
-
0 min